Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Mental Retardation and Developmental Disabilities Research Reviews|March 3, 2004
Prospects for gene therapy in the fragile X syndromeMario C Rattazzi, Giuseppe LaFauci, W Ted BrownGenes|December 13, 2016
Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP)Giuseppe LaFauci, Tatyana Adayev, Richard Kascsak, et al.Neurobiology of Disease|April 14, 2009
Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoformsWen Xie, Natalia Dolzhanskaya, Giuseppe LaFauci, et al.Acta Neuropathologica|May 17, 2008
The effect of amyloidosis-beta and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in cultureRadek Kolecki, Giuseppe Lafauci, Richard Rubenstein, et al.Biochimica Et Biophysica Acta|May 9, 2002
Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissuesEunkyue Park, Seung Yong Park, Chuanhua Wang, et al.Journal of Neurodevelopmental Disorders|May 5, 2017
Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxietyJessica Klusek, Giuseppe LaFauci, Tatyana Adayev, et al.The Journal of General Virology|February 11, 2012
PrP(Sc) detection and infectivity in semen from scrapie-infected sheepRichard Rubenstein, Marie S Bulgin, Binggong Chang, et al.The Journal of Molecular Diagnostics : JMD|May 11, 2013
Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassayGiuseppe LaFauci, Tatyana Adayev, Richard Kascsak, et al.Genes|October 23, 2021
Development of a Quantitative FMRP Assay for Mouse Tissue ApplicationsTatyana Adayev, Giuseppe LaFauci, Weimin Xu, et al.Scientific Reports|April 5, 2022
Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spotsAnna E Boggs, Lauren M Schmitt, Richard D McLane, et al.Pageof 2